Eculizumab

ATC L04AJ01 · 10 markets · 22 records

Eculizumab 10 markets · 22 records Forms

US 3 records · 1 strengths

300 mg/30 mLinjectionBKEMV+2EPYSQLI、SOLIRIS also in GB·AU·CN

GB 3 records · 1 strengths

300 mg/30 mLinjectionBekemv 300mg/30ml concentrate for solution for infusion vials+2Epysqli 300mg/30ml concentrate for solution for infusion vials、Soliris 300mg/30ml concentrate for solution for infusion vials also in US·AU·CN

AU 3 records · 3 strengths

300 mg/30 mLinjectionSOLIRIS also in US·GB·CN
300 mginjectionSOLIRIS eculizumab 300 mg/30 mL concentrated solution for intravenous infusion vial also in ES·TW unknown

Records without a stated strength · 1 SOLIRIS

ES 3 records · 1 strengths

300 mginjectionBEKEMV+2EPYSQLI、SOLIRIS also in AU·TW

EU 3 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Records without a stated strength · 1 BEKEMV、EPYSQLI、SOLIRIS

CA 2 records · 1 strengths

10 mgliquidEPYSQLI+1SOLIRIS

SG 1 records · 1 strengths

300 mg/vialinjectionSoliris Concentrate for Solution for Infusion 300mg/vial

CN 1 records · 1 strengths

300 mg/30 mLinjection舒立瑞依库珠单抗 also in US·GB·AU

TW 1 records · 1 strengths

300 mginjectionSoliris 300 mg concentrate for solution for infusion+1舒立瑞濃縮靜脈輸注液 300毫克 also in AU·ES

HK 1 records · 1 strengths

Records without a stated strength · 1 Soliris 300 mg concentrate for solution for infusion

Side-by-side table

Strength / form / release	US	GB	CA	AU	SG	CN	ES	TW	HK	EU
300 mg/30 mL injection	BKEMV EPYSQLI SOLIRIS	Bekemv 300mg/30ml concentrate for solution for infusion vials Epysqli 300mg/30ml concentrate for solution for infusion vials Soliris 300mg/30ml concentrate for solution for infusion vials	not recorded	SOLIRIS	not recorded	舒立瑞依库珠单抗	not recorded	not recorded	not recorded	not recorded
300 mg injection	not recorded	not recorded	not recorded	SOLIRIS eculizumab 300 mg/30 mL concentrated solution for intravenous infusion vial	not recorded	not recorded	BEKEMV EPYSQLI SOLIRIS	Soliris 300 mg concentrate for solution for infusion 舒立瑞濃縮靜脈輸注液 300毫克	not recorded	not recorded
10 mg liquid	not recorded	not recorded	EPYSQLI SOLIRIS	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
300 mg/vial injection	not recorded	not recorded	not recorded	not recorded	Soliris Concentrate for Solution for Infusion 300mg/vial	not recorded	not recorded	not recorded	not recorded	not recorded
not disclosed unknown	not recorded	not recorded	not recorded	SOLIRIS	not recorded	not recorded	not recorded	not recorded	Soliris 300 mg concentrate for solution for infusion	BEKEMV EPYSQLI SOLIRIS

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

2 more strength/form rows are recorded only in CA · SG and are not shown in this table. Hay 2 filas de concentración/forma registradas solo en CA · SG que no se muestran en esta tabla. 另有 2 个规格/剂型仅在 CA · SG 有记录（未在本表显示）。另有 2 個規格/劑型僅在 CA · SG 有記錄（未在本表顯示）。

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.